NATIONAL IMMUNODEFICIENCY STRATEGY

Primary immunodeficiencies (PIDs), also known as inborn errors of immunity (IEI), are a group of more than 400 potentially serious disorders, that can lead to frequent or severe infections, swellings and autoimmune problems. Symptoms often appear in childhood, but some can first occur in adults... The ASCIA Immunodeficiency Strategy for Australia and New Zealand was developed by ASCIA, the peak professional body of clinical immunology and allergy specialists in Australia and New Zealand, in consultation with patient organisations (AusPIPs, HAE Australasia, IDFA and IDFNZ), and other stakeholders. Whilst the main content of the Strategy was completed in November 2020, the final version of the Strategy is now available, to coincide with the International Day of Immunology and World PID Week.